Brain natriuretic Peptide production and secretion in inflammation
Tsuneo Ogawa1, Adolfo J de Bold
1Cardiovascular Endocrinology Laboratory, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, Canada K1Y 4W7.
Insights
Inflammation selectively increases brain natriuretic peptide (BNP) in cardiac disorders, unlike atrial natriuretic factor (ANF). This finding offers insights into cardiac inflammation and BNP regulation.
Area of Science:
- Cardiology
- Molecular Biology
- Immunology
Background:
- Cardiac polypeptide hormones atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP) are upregulated in cardiac disorders.
- Hemodynamic and neuroendocrine changes are key in cardiac disease progression.
- Acute cardiac allograft rejection elevates plasma BNP but not ANF.
Purpose of the Study:
- To investigate the selective regulation of BNP gene expression by inflammatory substances.
- To understand the differential response of ANF and BNP to inflammation in cardiac conditions.
Main Methods:
- Utilized cardiomyocyte cultures to study the effects of cytokines (TNFα and IL-1β) on ANF and BNP expression.
- Observed in vivo changes in plasma BNP levels during acute cardiac allograft rejection, sepsis, and acute myocarditis.
Main Results:
- Cytokines TNFα and IL-1β selectively stimulated cardiac BNP at transcriptional and translational levels in vitro.
- ANF expression was unaffected by these cytokines in cardiomyocyte cultures.
- Elevated plasma BNP levels were observed in vivo during acute cardiac allograft rejection, sepsis, and acute myocarditis, correlating with inflammation.
Conclusions:
- Inflammation, mediated by cytokines, selectively upregulates BNP gene expression and secretion in cardiomyocytes.
- This selective BNP response to inflammation is a significant factor in specific cardiac conditions like allograft rejection, sepsis, and myocarditis.
- BNP may serve as a more specific biomarker for inflammation-driven cardiac events compared to ANF.
Abstract:
Gene expression and secretion of the cardiac polypeptide hormones atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP) are simultaneously upregulated in various cardiac disorders such as congestive heart failure, ischemic heart disease, and hypertensive heart disease, in which hemodynamic or neuroendocrine changes are key components in the progression of disease. However, during acute cardiac allograft rejection, plasma BNP levels are increased but not those of ANF. Successful treatment of the rejection episode decreases the elevated plasma BNP to prerejection values suggesting that substances related to inflammation may selectively influence BNP gene expression. Indeed, cytokines such as TNFα and IL-1β selectively stimulate cardiac BNP at the transcriptional and translational levels in cardiomyocyte cultures without affecting ANF. This selective BNP increase is seen in vivo, in addition to acute cardiac allograft rejection, in several circumstances where inflammation significantly contributes to the pathogenesis of disease such as in sepsis and in acute myocarditis.
Related Concept Videos
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hormonal Regulation
Hormonal Regulation
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Inflammation III: Local and Systemic Effects
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...


